MIFH
IART icon

Migdal Insurance & Financial Holdings’s Integra LifeSciences IART Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,580
Closed -$161K – 723
2018
Q4 		$161K Buy
+3,580
New +$196K ﹤0.01% 404

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Migdal Insurance & Financial Holdings's IART Position: Q1 2019 in Review

Migdal Insurance & Financial Holdings sold out of Integra LifeSciences (IART) in Q1 2019, closing a stake of 3,580 shares — an estimated $161K sold.

Migdal Insurance & Financial Holdings first reported a position in IART in Q4 2018 and held it in 1 quarter. The position peaked at $161K in Q4 2018. 259 funds tracked by Wall St. Rank hold IART as of Q1 2019.

  • Migdal Insurance & Financial Holdings reported no remaining Integra LifeSciences position as of Q1 2019 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 3,580 Integra LifeSciences shares in Q1 2019, an estimated $161K.
  • Migdal Insurance & Financial Holdings first reported a position in Integra LifeSciences in Q4 2018 and held it in 1 quarter.
  • Migdal Insurance & Financial Holdings's Integra LifeSciences position peaked at $161K in Q4 2018.
  • 259 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2019.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2019, filed 1 May 2019.